Publications by authors named "Sergio Fava"

Claim this Profile
E
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
Andrea Luciani, Antonio Marra, Luca Toschi, Diego Cortinovis, Sergio Fava

Clin Lung Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry.
Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, Gaetano Facchini, Sergio Fava

J Glob Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoropyrimidine-Associated Toxicity in Two Gastrointestinal Cancer Patients: Potential Role of Common DPYD Polymorphisms.
Felicia Stefania Falvella, Marco Luoni, Stefania Cheli, Sergio Fava, Massimiliano Cergnul

Chemotherapy· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
Daniele Fagnani, Luciano Isa, Magda Franca Verga, Paola Nova, Clelia Casartelli, Sergio Fava

Tumori· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.
Andrés J M Ferreri, Giada Licata, Marco Foppoli, Gaetano Corazzelli, Emanuele Zucca, Sergio Fava

Oncologist· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
Ercole Brusamolino, Chiara Rusconi, Luigi Montalbetti, Livio Gargantini, Lilj Uziel, Sergio Fava

Haematologica· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, FrancoVito Piantedosi, Adolfo Favaretto, Sergio Fava

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma.
Alessandro Corso, Luciana Barbarano, Patrizia Zappasodi, Roberto Cairoli, Emilio Paolo Alessandrino, Sergio Fava

Haematologica· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care in patients with advanced non-small-cell lung cancer.
M Di Maio, F Perrone, C Gallo, R V Iaffaioli, L Manzione, Sergio Fava, Adolfo Favaretto

Br J Cancer· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Cesare Gridelli, Ciro Gallo, Frances A Shepherd, Alfonso Illiano, Francovito Piantedosi, Sergio Fava

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis